Home009420 • KRX
add
Hanall Biopharma Co Ltd
Previous close
₩36,000.00
Day range
₩35,000.00 - ₩36,400.00
Year range
₩20,850.00 - ₩46,750.00
Market cap
1.90T KRW
Avg Volume
512.50K
P/E ratio
414.53
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 34.09B | 18.36% |
Operating expense | 18.48B | 5.95% |
Net income | -323.32M | 74.21% |
Net profit margin | -0.95 | 78.16% |
Earnings per share | — | — |
EBITDA | 913.82M | 196.87% |
Effective tax rate | -753.80% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 48.18B | -19.11% |
Total assets | 221.52B | 5.92% |
Total liabilities | 43.31B | -0.03% |
Total equity | 178.20B | — |
Shares outstanding | 50.70M | — |
Price to book | 10.24 | — |
Return on assets | 0.13% | — |
Return on capital | 0.16% | — |
Cash Flow
Net change in cash
(KRW) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -323.32M | 74.21% |
Cash from operations | 775.79M | -90.26% |
Cash from investing | -4.07B | -33.29% |
Cash from financing | -133.67M | 28.21% |
Net change in cash | -3.42B | -163.60% |
Free cash flow | -9.75B | -220.29% |
About
Founded
1973
Headquarters
Website
Employees
306